TGF beta (type I, short)
Use this icon in our BioRender software along with 1000s of others. Create your next scientific figure in minutes!
SIGN UP FREE[{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a36/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a36/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a35/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a35/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a34/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a34/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a33/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a33/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a32/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a32/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a31/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a31/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a30/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a30/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a2f/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a2f/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a2e/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a2e/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a2d/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a2d/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a2c/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a2c/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a2b/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a2b/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a2a/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a2a/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a29/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a29/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a28/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a28/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a27/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a27/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a26/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a26/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a25/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a25/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a24/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a24/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a23/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a23/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a22/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a22/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a21/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a21/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a20/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a20/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a1f/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a1f/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a1e/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a1e/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a1d/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a1d/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a1c/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a1c/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a1b/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a1b/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a1a/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a1a/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a19/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a19/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a18/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a18/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a17/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a17/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a16/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a16/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a15/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a15/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a14/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a14/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a13/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a13/tgf-beta-type-i-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333325ef544890021309a12/tgf-beta-type-i-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333325ef544890021309a12/tgf-beta-type-i-short.png"}]
Keywords
TGF beta,transforming growth factor beta,serine kinase receptor,TGF β,TGF,beta,threonine kinase receptor,kinase receptor,type I,type II,type 1,type 2,serine,threonine,kinase,short,TGF